Attendees are invited to attend a
real-time, interactive tour of Khiron's recently completed Zerenia
medical facility
TORONTO, July 17, 2020 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF),
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, Khiron CEO and Director will lead
a live, on-camera virtual tour of the Company's recently completed
15,000 square foot Zerenia integrated medical facility located in
Bogota, Colombia.
Date: Tuesday, July 21st
Tour start: 9:00am ET
Participants: Alvaro Torres, Khiron CEO and Director,
together with popular Colombia
broadcaster Jorge Hernan Pelaez
RSVP
link: https://event.on24.com/wcc/r/2515378/7925EA0F958A3BFB29F9817DC1A8D4C1
This will be the first in a series of live, interactive events
present by Khiron. Attendees are invited to ask the Company
questions in real time, learn about the clinic operational model,
meet members of the medical team, and discuss the Zerenia health
and wellbeing advantages, including operations during the Covid-19
recovery. An archived recording will be available after the
event.
Recent Company Highlights:
- Becomes the first and, to date, only company fully authorized
to manufacture and sell high-THC medical cannabis for patient
prescriptions in Colombia
- Signs distribution deal for its Kuida™ CBD cosmeceutical brand
with Red Yellow Red, a leading EU
distributor of cosmetic products, bringing the Kuida brand to the
Spanish market
- Enters into an agreement with Nimbus Health, a leading German
distributor of medical cannabis products to bring Khiron branded EU
GMP medical cannabis to Germany
- Receives first medical cannabis prescriptions for patients
participating in the UK's Project Twenty21, Europe's largest study of the effectiveness
and tolerability of medical cannabis
About Khiron Life Sciences Corp.
Khiron is a vertically integrated medical and CPG cannabis
company with core operations in Latin
America, and operational activity in Europe and North America. Khiron is
the leading cannabis company in Colombia and the first company licensed
in Colombia for the cultivation, production, domestic
distribution, and international export of both low and high THC
medical cannabis products. The Company has presence in Mexico, Peru,
Uruguay, Brazil, UK and Germany, where it is positioned to begin sales
of medical cannabis.
Leveraging its first-mover advantage, and patient oriented
approach, Khiron combines global scientific expertise, product
innovation, agricultural infrastructure, wholly-owned medical
clinics, and online doctor education programs to drive prescription
and brand loyalty to address priority medical conditions. Its
Wellbeing unit launched the first branded CBD skincare brand in
Colombia, with Kuida now marketed
in multiple jurisdictions in Latin
America, the US and UK. The Company is led by Co-founder and
Chief Executive Officer, Alvaro
Torres, together with an experienced and diverse
executive team and Board of Directors.
Visit Khiron online at www.khiron.ca,
investors.khiron.ca and on Instagram @khironlife
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment analyses,
expectations or statements made by third-parties in respect of
Khiron, its securities, or financial or operating results (as
applicable). Although Khiron believes that the expectations
reflected in forward-looking statements in this press release are
reasonable, such forward-looking statement has been based on
expectations, factors and assumptions concerning future events
which may prove to be inaccurate and are subject to numerous risks
and uncertainties, certain of which are beyond Khiron's control,
including the risk factors discussed in Khiron's Annual Information
Form which is available on Khiron's SEDAR profile at www.sedar.com.
The forward-looking information contained in this press release is
expressly qualified by this cautionary statement and are made as of
the date hereof. Khiron disclaims any intention and has no
obligation or responsibility, except as required by law, to update
or revise any forward-looking information, whether as a result of
new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/vamos-colombia-khiron-hosts-live-virtual-medical-facility-tour-301095386.html
SOURCE Khiron Life Sciences Corp.